Scottsdale Weight Loss Center’ Physicians Celebrate the FDA Approval of Lorcaserin
New weight loss drug brings hope to patients with obesity.
Craig Primack MD and Robert Ziltzer MD have new medical options when treating patients affected by obesity
Scottsdale, Arizona June 27, 2012 — Lorcaserin (Belviq-Arena Pharmaceuticals, San Diego), is a new and unique drug; it’s the first drug for weight loss to work by specifically targeting the 5-HT2c brain’s serotonin receptors. These receptors when triggered promote fullness. This fullness results in weight loss.
“It’s a new weight loss tool that is long overdue,” states Craig Primack MD. He continues “I literally jumped up and down when I heard the news today.” “This is huge news, one that brings hope to patients with this challenging disease,” added Robert Ziltzer MD.
With 2/3 of the population overweight or obese, doctors are concerned about the lack of new tools for treatment. Finally, the Food & Drug Administration reversed course and has approved Lorcaserin a new weight loss and weight management medication.
Overweight and Obese patients and their medical obesity specialist physicians need a variety of tools including medications for obesity treatment, since any one treatment does not work for every patient. In addition to the proper diet, exercise, sleep and behavior changes we believe this tool will become a wonderful new addition to obesity treatment.
About Scottsdale Weight Loss Center
Scottsdale Weight Loss Center is a medical weight loss clinic in Scottsdale and Chandler, Arizona that has helped patients loss over 98,000 pounds since June, 2006. This leading weight loss center assists patients in reaching their target weight through custom programs and helps them maintain their desired weight through active weight management solutions. Scottsdale Weight Loss Center’s Dr. Robert Ziltzer, MD and Dr. Craig Primack, MD are board-certified in Obesity Medicine/Bariatrics, Internal Medicine and Pediatrics. For more information, visit scottsdaleweightloss.com.